Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome

Prader-Willi syndrome (PWS), an imprinting disorder, results from the loss of expression of a paternal gene on chromosome 15q11-q13. Progressive obesity and its associated complications lead to increased morbidity and early death in PWS patients. The management techniques available for morbid obesit...

Full description

Bibliographic Details
Main Authors: Yoo-Mi Kim, Yeoun Joo Lee, Soo Yeon Kim, Chong Kun Cheon, Han Hyuk Lim
Format: Article
Language:English
Published: Korean Society of Pediatric Endocrinology 2020-03-01
Series:Annals of Pediatric Endocrinology & Metabolism
Subjects:
Online Access:http://e-apem.org/upload/pdf/apem-2020-25-1-52.pdf
_version_ 1818902686640111616
author Yoo-Mi Kim
Yeoun Joo Lee
Soo Yeon Kim
Chong Kun Cheon
Han Hyuk Lim
author_facet Yoo-Mi Kim
Yeoun Joo Lee
Soo Yeon Kim
Chong Kun Cheon
Han Hyuk Lim
author_sort Yoo-Mi Kim
collection DOAJ
description Prader-Willi syndrome (PWS), an imprinting disorder, results from the loss of expression of a paternal gene on chromosome 15q11-q13. Progressive obesity and its associated complications lead to increased morbidity and early death in PWS patients. The management techniques available for morbid obesity in adolescents and adults with PWS are limited. Herein, we report successful weight reduction in an adolescent PWS case showing morbid obesity and respiratory failure. An 18-year-old girl with PWS presented with diffuse cellulitis and dyspnea due to severe obesity. Her body weight had increased from 146 to 161 kg despite dietary restriction to 800 kcal/day, and a mechanical ventilator was required for dyspnea. During mechanical ventilation, the patient was managed using diuretics and by restricting fluid intake; her daily calorie intake was reduced to 200 kcal. This aggressive calorie and water restriction continued for 3 weeks and reduced her body weight to 118.6 kg. After transfer to the general ward, the patient was provided with growth hormone therapy and intensive aquatic rehabilitation and was administered liraglutide; as a result, her weight further decreased to 104 kg (body mass index [BMI], 50.8 kg/m2), and she was discharged. Following discharge, she maintained her BMI and adapted to 1,000 kcal/day for 1 year. Aggressive water and calorie restriction were observed as an effective method for rapid weight reduction in PWS patients, and liraglutide appeared useful in maintaining weight reduction in adolescent and adult PWS.
first_indexed 2024-12-19T20:39:36Z
format Article
id doaj.art-0f5659f6031a488f98fb7ae3a632eff3
institution Directory Open Access Journal
issn 2287-1012
2287-1292
language English
last_indexed 2024-12-19T20:39:36Z
publishDate 2020-03-01
publisher Korean Society of Pediatric Endocrinology
record_format Article
series Annals of Pediatric Endocrinology & Metabolism
spelling doaj.art-0f5659f6031a488f98fb7ae3a632eff32022-12-21T20:06:26ZengKorean Society of Pediatric EndocrinologyAnnals of Pediatric Endocrinology & Metabolism2287-10122287-12922020-03-01251525610.6065/apem.2020.25.1.52804Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndromeYoo-Mi Kim0Yeoun Joo Lee1Soo Yeon Kim2Chong Kun Cheon3Han Hyuk Lim4 Department of Pediatrics, Chungnam National University Hospital, Chungnam National College of Medicine, Daejeon, Korea Department of Pediatrics, Pusan National University Children’s Hospital, Pusan National College of Medicine, Yangsan, Korea Department of Rehabilitation, Pusan National University Children’s Hospital, Pusan National College of Medicine, Yangsan, Korea Department of Pediatrics, Pusan National University Children’s Hospital, Pusan National College of Medicine, Yangsan, Korea Department of Pediatrics, Chungnam National University Hospital, Chungnam National College of Medicine, Daejeon, KoreaPrader-Willi syndrome (PWS), an imprinting disorder, results from the loss of expression of a paternal gene on chromosome 15q11-q13. Progressive obesity and its associated complications lead to increased morbidity and early death in PWS patients. The management techniques available for morbid obesity in adolescents and adults with PWS are limited. Herein, we report successful weight reduction in an adolescent PWS case showing morbid obesity and respiratory failure. An 18-year-old girl with PWS presented with diffuse cellulitis and dyspnea due to severe obesity. Her body weight had increased from 146 to 161 kg despite dietary restriction to 800 kcal/day, and a mechanical ventilator was required for dyspnea. During mechanical ventilation, the patient was managed using diuretics and by restricting fluid intake; her daily calorie intake was reduced to 200 kcal. This aggressive calorie and water restriction continued for 3 weeks and reduced her body weight to 118.6 kg. After transfer to the general ward, the patient was provided with growth hormone therapy and intensive aquatic rehabilitation and was administered liraglutide; as a result, her weight further decreased to 104 kg (body mass index [BMI], 50.8 kg/m2), and she was discharged. Following discharge, she maintained her BMI and adapted to 1,000 kcal/day for 1 year. Aggressive water and calorie restriction were observed as an effective method for rapid weight reduction in PWS patients, and liraglutide appeared useful in maintaining weight reduction in adolescent and adult PWS.http://e-apem.org/upload/pdf/apem-2020-25-1-52.pdfliraglutideprader-willi syndromeadolescentobesitymorbid
spellingShingle Yoo-Mi Kim
Yeoun Joo Lee
Soo Yeon Kim
Chong Kun Cheon
Han Hyuk Lim
Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
Annals of Pediatric Endocrinology & Metabolism
liraglutide
prader-willi syndrome
adolescent
obesity
morbid
title Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
title_full Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
title_fullStr Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
title_full_unstemmed Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
title_short Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
title_sort successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent prader willi syndrome
topic liraglutide
prader-willi syndrome
adolescent
obesity
morbid
url http://e-apem.org/upload/pdf/apem-2020-25-1-52.pdf
work_keys_str_mv AT yoomikim successfulrapidweightreductionandtheuseofliraglutideformorbidobesityinadolescentpraderwillisyndrome
AT yeounjoolee successfulrapidweightreductionandtheuseofliraglutideformorbidobesityinadolescentpraderwillisyndrome
AT sooyeonkim successfulrapidweightreductionandtheuseofliraglutideformorbidobesityinadolescentpraderwillisyndrome
AT chongkuncheon successfulrapidweightreductionandtheuseofliraglutideformorbidobesityinadolescentpraderwillisyndrome
AT hanhyuklim successfulrapidweightreductionandtheuseofliraglutideformorbidobesityinadolescentpraderwillisyndrome